FRNM Freenome Inc

Q: Which ETFs hold FRNM?

Freenome Inc (FRNM) is held by 1 fund tracked by ETFpeek as of 9 Oct 2026: ARKG (0.72%).

Which ETFs hold FRNM? Freenome Inc is held by 1 fund tracked by ETFpeek.

Held by 1 fund todayData as of 9 Oct 2026

HealthcareDiagnostics & Research

$15.81

+48.7% 1y

$9.9552-week range$17.50

Market cap

$1.8B

3-month

+46.4%

CEO

Mr. Aaron Elliott Ph.D.

Revenue growth (YoY)

+106.5%

Freenome, Inc., a biotechnology company, develops blood-based screening tests to detect cancer in the United States. The company offers an early cancer detection platform that integrates multiomics, artificial intelligence, and machine learning to uncover complex biological signals associated with cancer. It develops SimpleScreen CRC, a blood-based test, including a test for colorectal cancer screening, as well as tests for multi-cancer and multi-disease detection, such as lung, breast, cervical, liver, pancreatic, and esophageal cancers. The company was founded in 2014 and is headquartered in Brisbane, California.

Currently Held By

ARK

ARKG

ARK Genomic Revolution ETF

Not held by the selected provider.

Insider Activity i

last 90 days

Net flow (90d):+$107.6M (17 without value)·14 BUY / 6 SELL·score ≥ 40

Date	Person	Action	Plan	Shares	Value	Score i
20 Jul 2026	Capital Solutions Holdings Perceptive Director / Other	SELL	Unknown	2,066,250	—	70
20 Jul 2026	Capital Solutions Holdings Perceptive Director / Other	BUY	Unknown	2,066,250	—	70
20 Jul 2026	Michael Seth Altman Director / Other	SELL	Unknown	2,066,250	—	70
20 Jul 2026	Michael Seth Altman Director / Other	BUY	Unknown	2,066,250	—	70
20 Jul 2026	Adam Leo Stone Director / Other	SELL	Unknown	2,066,250	—	70
20 Jul 2026	Adam Leo Stone Director / Other	BUY	Unknown	2,066,250	—	70

Net flow (90d):+$107.6M (17 without value)·14 BUY / 6 SELL·showing all trades

Date	Person	Action	Plan	Shares	Value	Score i
20 Jul 2026	Capital Solutions Holdings Perceptive Director / Other	SELL	Unknown	2,066,250	—	70
20 Jul 2026	Capital Solutions Holdings Perceptive Director / Other	BUY	Unknown	2,066,250	—	70
20 Jul 2026	Michael Seth Altman Director / Other	SELL	Unknown	2,066,250	—	70
20 Jul 2026	Michael Seth Altman Director / Other	BUY	Unknown	2,066,250	—	70
20 Jul 2026	Adam Leo Stone Director / Other	SELL	Unknown	2,066,250	—	70
20 Jul 2026	Adam Leo Stone Director / Other	BUY	Unknown	2,066,250	—	70
20 Jul 2026	Harlan Waksal Director / Other	SELL	Unknown	30,000	—	30
20 Jul 2026	Harlan Waksal Director / Other	BUY	Unknown	30,000	—	30
20 Jul 2026	Kenneth Song Director / Other	SELL	Unknown	30,000	—	30
20 Jul 2026	Kenneth Song Director / Other	BUY	Unknown	30,000	—	30
20 Jul 2026	Mark C. McKenna Director / Other	SELL	Unknown	30,000	—	30
20 Jul 2026	Mark C. McKenna Director / Other	BUY	Unknown	30,000	—	30
20 Jul 2026	Capital Management, L.P. Ra Director / Other	BUY	Vested (RSU)	14,617,270 7 tranches	$52.6M	30
20 Jul 2026	Advisors LLC Perceptive Director / Other	BUY	Vested (RSU)	5,500,000	$55.0M	30

Data: Finnhub (SEC Form 4 filings) · Score: ETFpeek heuristic

Trade History

12 trades

Date	Fund	Direction	Shares Changed	% Δ ETF i	% Δ Position i
9 Oct 2026	ARKG	BUYAdded	+67,305	+0.05%	7.25%
8 Oct 2026	ARKG	BUYAdded	+39,983	+0.04%	4.56%
7 Oct 2026	ARKG	BUYAdded	+35,591	+0.07%	4.24%
6 Oct 2026	ARKG	BUYAdded	+47,085	+0.02%	5.76%
27 Aug 2026	ARKG	BUYAdded	+14,542	+0.01%	1.92%
25 Aug 2026	ARKG	BUYAdded	+12,939	+0.02%	1.76%
24 Aug 2026	ARKG	BUYAdded	+15,995	+0.00%	2.21%
21 Aug 2026	ARKG	BUYAdded	+46,145	+0.03%	6.85%
20 Aug 2026	ARKG	BUYAdded	+55,170	+0.00%	8.71%
19 Aug 2026	ARKG	BUYAdded	+59,280	+0.07%	10.52%
18 Aug 2026	ARKG	BUYAdded	+144,595	+0.14%	28.63%
17 Aug 2026	ARKG	BUYNew position	+360,470	+0.24%	100.00%
No trade history for SmartShares funds — their underlying ETFs are passive index trackers, so day-to-day rebalancing is minimal.

FRNM Freenome Inc

Currently Held By

Insider Activity i

Trade History

More stocks in these funds